ABSTRACT: Bone fractures are among the most common orthopaedic problems that affect individuals of all ages. Immediately after injury, activated macrophages dynamically contribute to and regulate an acute inflammatory response that involves other cells at the injury site, including mesenchymal stem cells (MSCs). These macrophages and MSCs work in concert to modulate bone healing. In this study, we co-cultured undifferentiated M0, pro-inflammatory M1, and anti-inflammatory M2 macrophages with primary murine MSCs in vitro to determine the cross-talk between polarized macrophages and MSCs and their effects on osteogenesis. After 4 weeks of coculture, MSCs grown with macrophages, especially M1 macrophages, had enhanced bone mineralization compared to MSCs grown alone. The level of bone formation after 4 weeks of culture was closely associated with prostaglandin E2 (PGE2) secretion early in osteogenesis. Treatment with celecoxib, a cyclooxygenase-2 (COX-2) selective inhibitor, significantly reduced bone mineralization in all co-cultures but most dramatically in the M1-MSC co-culture. We also found that the presence of macrophages reduced the secretion of osteoprotegerin (OPG), the decoy RANKL receptor, suggesting that macrophages may indirectly modulate osteoclast activity in addition to enhancing bone formation. Taken together, these findings suggest that an initial pro-inflammatory phase modulated by M1 macrophages promotes osteogenesis in MSCs via the COX-2-PGE2 pathway. Understanding the complex interactions between macrophages and MSCs provide opportunities to optimize bone healing and other regenerative processes via modulation of the inflammatory response. This study provides one possible biological mechanism for the adverse effects of non-steroidal antiinflammatory drugs on fracture healing and bone regeneration. ß
Bone fractures are among the most common orthopaedic problems that affect individuals of all ages. In the United States alone, nearly 3.5 million emergency department visits and 900,000 hospitalizations result from bone fractures annually. 1 Five to ten percent of bone fractures result in delayed healing or nonunion, and these failures may require extensive surgery to achieve complete bone healing, presenting a multibillion dollar cost to society. 2, 3 In addition to surgical interventions, strategies to enhance bone regeneration in these situations are limited. Thus, it is imperative to gain a better understanding of bone repair at the cellular-molecular level for optimal bone healing.
After acute bone injury, an inflammatory cascade is initiated by local tissue macrophages and polymorphonuclear neutrophils (PMNs) that secrete chemokines (e.g., CCL2 and IL-6) to attract circulating monocytes and macrophages. 4, 5 These recruited macrophages contribute to osteogenesis and initiate bone repair by clearing debris, stimulating angiogenesis, attracting, and promoting osteogenic differentiation of mesenchymal stem cells (MSCs), and increasing extracellular matrix synthesis. [5] [6] [7] As a result of this inflammatory milieu, different macrophage phenotypes arise: Undifferentiated M0, pro-inflammatory M1, and anti-inflammatory M2. Given the plasticity of macrophages and their tissueand context-specific phenotypes, there is debate regarding the existence of the undifferentiated M0 phenotype in vivo; however, polarized macrophages have been shown to drive MSC differentiation towards osteoblasts and promote bone mineralization. [8] [9] [10] [11] M2 macrophages and their cytokines have been shown to support the growth of human MSCs (hMSCs) while M1 macrophages and their pro-inflammatory cytokines inhibit hMSC growth. 12 However, other studies have shown that direct M1 interaction with murine MSCs and MC3T3 cells (osteoprogenitor cell line) increases osteogenesis and bone mineralization, especially when M1 macrophages are induced to the M2 phenotype after 72 h of co-culture. 10, 13 These data reveal the importance of acute initial inflammation in bone healing but also highlight the need to further investigate the complex dynamics between polarized macrophages and MSCs.
In clinical practice, non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for the treatment of musculoskeletal pain. NSAIDs such as naproxen are non-selective cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors. COX-1 is constitutively active and plays a homeostatic role in the gastrointestinal system, kidney, and platelet function whereas COX-2 is a stress response gene that is responsible for the conversion of arachidonic acid to prostaglandins like prostaglandin E2 (PGE2) during inflammation. 14 Various clinical and preclinical studies suggest that cyclooxygenase play a key role in bone repair, and thus, the use of NSAIDs may negatively alter the natural bone healing process. Non-selective NSAIDs have been shown to delay or even completely inhibit fracture healing in rats. 15, 16 In a retrospective review of human femoral fractures, Giannoudis et al. found that there was a higher incidence of non-unions in patients who had used NSAIDs than those who did not. 17 COX-2 activity has been specifically identified to be involved in maximal induction of osteogenesis. 18 Zhang et al. showed that osteogenesis was impaired in COX-2 knockout mice, and that addition of PGE2, a COX-2 metabolite, completely rescued the COX-2-deficient phenotype. 18 However, controversy over the effect of COX-2 inhibitors and other NSAIDs in clinical practice still persists even after decades of research. Several spinal fusion studies have shown no difference in fracture healing with the treatment of COX-2 selective inhibitors, but impaired healing from other causes such as smoking. [19] [20] [21] [22] With these conflicting results, it is apparent that a better understanding is required to appreciate the nuances of COX-2 activity in musculoskeletal health.
In this study, we utilized a co-culture system to elucidate the cross-talk among primary murine undifferentiated M0, polarized macrophages (M1 and M2), and primary MSCs in osteogenesis and bone mineralization. We found that polarized macrophages, especially pro-inflammatory M1 macrophages, promote bone mineralization in MSCs after 4 weeks of coculture via the COX-2-PGE2 pathway. Further, we found that macrophages also reduce OPG secretion and thus may indirectly affect osteoclast activity via the OPG-RANKL axis in addition to enhancing bone formation. These findings highlight the importance of a robust, initial pro-inflammatory phase mediated by M1 macrophages in a macrophage-MSC co-culture system and have potential for optimizing fracture therapies.
METHODS Primary Mouse Bone Marrow Macrophage Isolation
The animal protocol was approved by the Stanford University Animal Care Committee. Primary bone marrow macrophages were isolated from the femora and tibiae of 8-weekold Jackson male C57BL-6J mice (The Jackson Laboratory, Bar Harbor, ME). Using a 25-gauge needle, the bone marrow was flushed into a 50 ml centrifuge tube with 5 ml of basal medium (RPM1 1640 [Life Technologies, Pleasanton, CA], 10% FBS, 1Â Antibiotic-Antimycotic). The cells were then filtered through a 70 mm cell strainer, spun down at 400g for 10 min, and resuspended in 1 ml of ice-cold red blood cell lysis buffer (Sigma-Aldrich, St. Louis, MO) for 2 min at 4˚C. After addition of 20 ml basal medium, cells were spun down at 400g for 10 min and resuspended in 5 ml of macrophage media (RPMI 1640, 30% leukocyte-conditioned medium,10 ng/ml macrophage colony-stimulating factor [M-CSF], antibiotics). Cells were counted and placed into T-175 flasks (BD, Franklin Lakes, NJ) at a concentration of 50 Â 10 6 cells/ flask in 25 ml macrophage media. After 5-7 days in culture, the macrophages were lifted with trypsin-EDTA (Life Technologies) and gentle scraping and frozen in liquid nitrogen for subsequent experiments.
Primary Mouse Mesenchymal Stem Cell Isolation
Primary mouse MSCs were isolated from the femora and tibiae of 8-week-old Jackson male C57BL-6J mice. Using a 27-gauge needle, the bone marrow was flushed into a 10 cm dish and resuspended in MSC growth media (a-MEM, 10% heat inactivated MSC qualified FBS, 1Â Anti-Anti). The cells were filtered through a 70 mm cell strainer, spun down at 400g for 5 min, resuspended in media, and plated onto T-175 flasks. The cells were then incubated overnight in 37˚C at 5% CO 2 , and the media was changed with 20 ml fresh media twice a week for 3-4 weeks until the cells were confluent. Cells were washed with 10 ml PBS, detached with 5 ml trypsin, and incubated for 2 min. Detached cells were flushed with 10 ml media into a centrifuge tube and spun at 400g for 5 min. Cells were resuspended and plated at a 4,000 cells/cm 2 density. This subculture protocol was repeated twice until pure MSCs were isolated in passage 4. The immunophenotypes (Sca1þ/CD73þ/CD90.2þ/CD105þ/CD34À/CD45À) of pure MSCs at passage four were confirmed by flow cytometry and were used for this study. 23 
Macrophage Polarization
Macrophage polarization was performed following our previously established protocols. 13, 24 M0 cells were grown in macrophage media. 100 ng/ml LPS (Sigma-Aldrich) or 20 ng/ml IL-4 (R&D Systems, Minneapolis, MN) were added to the macrophage culture media to polarize M0 macrophages into M1 or M2 phenotypes, respectively. Macrophages were polarized for 24 h. This protocol has been shown to reliably produce M0, M1, and M2 macrophages as previously assessed by flow cytometry, qRT-PCR, and cytokine secretion profile. 13, 24 After 24 h of polarization by their respective stimuli, M0, M1, and M2 macrophages were co-cultured with MSCs in fresh mixed osteogenic-macrophage media that did not contain LPS or IL-4.
Macrophage-MSC Direct Co-Culture
Primary polarized macrophages and primary MSCs were seeded together at a 1:1 macrophage:MSC ratio (10 4 cells/ well each in a 24-well plate) and at a 5:1 ratio (5 Â 10 4 macrophages and 10 4 MSCs in each well). Co-cultures were cultured for 4 weeks in mixed osteogenic-macrophage media comprised of 50% macrophage media and 50% osteogenic media (Dulbecco's modified Eagle's medium, 10% FBS, 1% Penstrep, 100 mg/ml ascorbic acid, and 10 mM bglycerophosphate, 100 nM dexamethasone). Control groups included MSCs grown alone in normal MSC growth media (MSC-GM) and MSCs grown alone in mixed osteogenicmacrophage media (MSC-MM). To determine the effect of PGE2 inhibition on bone mineralization, co-cultures were treated with 25 mM of celexocib (Sigma, resuspended in sterile DMSO), a COX-2 selective inhibitor, for the first week of the 4-week culture.
Measuring Osteogenesis
To assess the osteogenic potential of the co-cultures, Alkaline Phosphatase (ALP) activity assays were conducted on cell lysates at 2 weeks of co-culture using the QuantiChrom Alkaline Phosphatase Assay Kit (DALP-250, BioAssay Systems, Hayward, CA) following manufacturer's protocol. At 4 weeks, bone mineralization was measured using Alizarin Red staining (pH 4.2; Sigma-Aldrich). Results were imaged for qualitative data. To quantify Alizarin Red stain, each well had 10% cetylpyridinium chloride solution added, and samples were measured via spectrophotometry at absorbance 562 nm in triplicate using a SpectraMax M2e spectrophotometer (Molecular Devices, Sunnyvale, CA).
Enzyme-Linked Immunosorbent Assays (ELISAs) ELISAs (R&D Systems, Biomedical Technologies, Stoughton, MA) for prostaglandin E2 (PGE2) and osteoprotegerin (OPG) were performed on supernatants taken at 2 and 3 weeks, respectively, following manufacturer's protocol.
Statistical Analysis
To compare different effects in osteogenesis of polarized macrophages (M0, M1, M2) on MSCs, one-way analysis of variance (ANOVA) followed by Tukey's test was performed via GraphPad Prism. We used p < 0.05 as the threshold for statistical significance. Data were presented as mean AE standard deviation.
RESULTS

Macrophages, Especially Pro-Inflammatory M1 Macrophages, Enhance Bone Mineralization
Initially, macrophages and MSCs were co-cultured at a 1:1 ratio (10k macrophages: 10k MSCs). After 4 weeks of culture, there was no significant difference in bone mineralization among MSCs grown alone and all coculture groups (data not shown), which is consistent with findings observed by Loi et al. in a similar macrophage-MC3T3 (osteoprogenitor cell line) coculture system. 25 Thus, we increased the macrophage: MSC seeding density to 5:1 (50k macrophages:10k MSCs) based on work done by Nicolaidou et al. in which increasing the ratio of non-polarized human macrophages:human MSCs allowed for increased bone mineralization, especially when macrophages and MSCs had direct cell-to-cell contact in co-culture. 11 At this higher seeding density, there was increased bone mineralization in all macrophage-MSC co-cultures regardless of macrophage phenotype (Fig. 1B) . All cultures containing macrophages had significantly enhanced bone mineralization compared to MSCs grown alone in mixed osteogenic-macrophage media (MSC-MM vs. M0-MSC p ¼ 0.0060, MSC-MM vs. M1-MSC p < 0.0001, MSC-MM vs. M2-MSC p < 0.0001) (Fig. 1B) . The effect was most prominent in pro-inflammatory M1-MSC cocultures, which had significantly higher bone formation compared to both MSCs grown alone and non-polarized M0-MSC co-cultures (p ¼ 0.0060) (Fig. 1B) .
M1-MSC Co-Cultures Exhibit Low ALP Activity Early in Osteogenesis
At 2 weeks of culture, MSCs co-cultured with M1 macrophages had reduced alkaline phosphatase (ALP) activity (1.28 AE 0.42 mmol/L Â min) compared to MSCs grown alone, M0-MSC, and M2-MSC groups (2.38 AE 1.10 mmol/L Â min, 9.30 AE 3.02 mmol/L Â min, 8.78 AE 1.00 mmol/L Â min, respectively) (Fig. 1A) . Both the undifferentiated M0-MSC and anti-inflammatory M2-MSC groups had significantly higher ALP Activity compared to M1-MSC and MSCs grown alone (Fig. 1A) . Despite low ALP activity early in co-culture, the M1-MSC culture had the greatest bone formation by 4 weeks (Fig. 1B) .
Macrophage-MSC Co-Cultures Have Elevated Levels of PGE2 Early in Osteogenesis
Macrophage-MSC co-cultures demonstrated elevated levels of PGE2 early in osteogenesis ( Fig. 2A) . After 2 weeks of culture, co-cultures with either M1 or M2 macrophages exhibited more PGE2 protein secretion than in MSCs grown alone and in M0-MSC co-cultures ( Fig. 2A ). M1-MSC had the highest PGE2 secretion (442.56 AE 76.74 pg/ ml) while M0-MSC and M2-MSC had lower PGE2 present in the supernatant (330.99 AE 70.55 pg/ml and 409.00 AE 69.22pg/ml, respectively) ( Fig. 2A) . M1-MSC Figure 1 . Polarized macrophages, especially proinflammatory M1 macrophages, enhance bone mineralization. Macrophages and MSCs were plated at an initial seeding density of 50k macrophages: 10k MSCs. At 2 weeks of culture, ALP activity was low in all groups, but was the lowest in M1-MSC (A). Both M0-MSC and M2-MSC had significantly higher ALP activity than M1-MSC and MSCs grown alone (A). After 4 weeks of culture, all macrophage-MSC cocultures had enhanced bone mineralization by Alizarin Red staining compared to MSCs grown alone in mixed osteogenic-macrophage media (B). The effect was most prominent in the M1-MSC group, which had significantly more bone mineralization than M0-MSC and MSCs grown alone (B). Despite early inhibition of osteogenesis in M1-MSC, M1-MSC exhibited the most bone formation at 4 weeks (B).
PGE2 secretion was not statistically significant compared to M2-MSC (p ¼ 0.44) (Fig. 2A) . PGE2 protein secretion is reported in absolute value of pg/ml.
Inhibition of COX-2 Reduces Bone Mineralization in
Macrophage-MSC Co-Cultures, Especially in M1-MSC CoCultures As increased PGE2 protein secretion was associated with increased bone mineralization, co-cultures were treated with celecoxib, a selective COX-2 inhibitor, to determine the effect PGE2 reduction on bone mineralization. With 1-week treatment of celecoxib at 25 mM, PGE2 protein secretion was abolished with PGE2 levels less than 20 pg/ml after 2 weeks of culture (1 week post-celecoxib treatment) (Fig. 2B) . After 4 weeks of culture, all co-culture groups had reduced bone mineralization compared to MSCs grown alone (p < 0.0001), especially in the M1-MSC group (Fig. 3B ).
There was no significant difference in ALP activity across co-culture groups and MSCs grown alone at 2 weeks of culture (Fig. 3A) .
Osteoprotegerin (OPG) Is Negatively Regulated by Macrophages in Macrophage-MSC Co-Culture After 3 weeks of culture, OPG, the decoy receptor for RANKL, protein secretion was decreased in all noncelecoxib-treated co-culture groups compared to MSCs grown alone (Fig. 4) . OPG secretion was significantly lower in both polarized macrophage co-culture groups (M1-MSC and M2-MSC) compared to the undifferentiated M0-MSC group and MSCs grown alone (Fig. 4) . RANKL protein secretion was also measured but was not detectable (<31.3 pg/ml) after 3 weeks of culture. This suggests that macrophages, especially polarized macrophages, decrease OPG secretion in co-culture and thus may indirectly regulate osteoclast activity in addition to enhancing bone mineralization.
DISCUSSION
In this study, we examined the effects of polarized macrophages on MSC differentiation and bone mineralization. Our data showed that macrophages, especially pro-inflammatory M1 macrophages, promote osteogenesis and bone mineralization of MSCs early in co-culture via the COX-2-PGE2-pathway. In our coculture system, all MSCs grown in the presence of macrophages exhibited high levels of PGE2 and low ALP activity at 2 weeks. However, despite low ALP activity at 2 weeks of co-culture, all macrophage-MSC co-cultures, especially M1-MSC, had enhanced bone mineralization compared to MSCs grown alone at 4 weeks of culture. Treatment with celecoxib, a selective COX-2 inhibitor, significantly reduced bone formation in all macrophage-MSC co-cultures with the most dramatic effect seen in the M1-MSC group (44.0% reduction compared to MSCs grown alone). These results highlight the importance of an initial, transient inflammatory phase mediated by macrophage-MSC cross-talk for optimal bone healing. It is well established that MSCs activate macrophages toward the anti-inflammatory M2 phenotype and exert an immunosuppressive response for the resolution of inflammation. [26] [27] [28] [29] [30] These immune modulatory effects require direct cell-cell contact with Figure 2 . Polarized macrophage-MSC co-cultures have elevated levels of PGE2 early in osteogenesis. After 2 weeks of culture, all macrophage-MSC cocultures demonstrated elevated levels of PGE2 compared to MSCs grown alone (A). M1-MSC had significantly higher PGE2 than M0-MSC but not significantly higher PGE2 than M2-MSC (p ¼ 0.44) (A). Interestingly, PGE2 protein expression at 2 weeks did not correlate with ALP activity at 2 weeks; trends more closely resembled bone mineralization at 4 weeks (A). Co-cultures were treated with 25 mM of celexocib for the first week of culture, and PGE2 protein expression was nearly abolished at 2 weeks of culture (1 week post-celecoxib treatment) (B). 33 PGE2 binds EP2 and EP4 receptors on macrophages that increase the production of anti-inflammatory IL-10. Similarly, activation of TLR4 on macrophages induces signaling through the COX-2 and PGE2 regulatory loop via STAT3 and increases the secretion of oncostatin M (OSM), a cytokine of the IL-6 family. 10, 11, 33 As both MSCs and macrophages can secrete PGE2 and modulate COX2 activity, this dynamic crosstalk might work to enhance osteogenesis by inducing osteoblast differentiation and increasing matrix mineralization possibly via autocrine and paracrine signaling. 10, [34] [35] [36] In our study, exposing MSCs to a high density of pro-inflammatory M1 macrophages may have best stimulated MSCs to reach their full pro-osteogenic potential and immune modulatory effect by reciprocally modulating macrophage phenotypes from M1 to M2 early in osteogenesis. Compared to the M2-MSC co-cultures, having a strong initial environment of M1 pro-inflammatory signaling may have allowed for a more potent activation of MSCs to secrete higher levels of PGE2 and other anti-inflammatory signals that enhance osteoblast differentiation and modulate an ideal transition of macrophages from the M1 to M2 phenotype. 37 Given the known tendency for macrophages to assume the M2 phenotype in the presence of MSCs, the differences in bone mineralization between the M1-MSC and M2-MSC groups highlight that these immunomodulatory effects are exerted early in osteogenesis and may be due to a more pro-osteogenic and precisely timed M1 to M2 transition. 13, 26, [28] [29] [30] Further, by co-culturing M1 macrophages at a 5:1 macrophage: MSC ratio, we provided a more robust pro-inflammatory environment that likely modeled the physiologic conditions present at the fracture site more closely than the 1:1 macrophage:MSC ratio. 5, 11 In a polarized macrophage-MC3T3 (osteoprogenitor cell line) co-culture system, our group has previously shown that enhanced osteogenesis can be achieved by transitioning M1 macrophages to the M2 phenotype via addition of IL-4 after 72 h of co-culture. 13 Similarly, we have also observed that adding IL-4 to primary M1-MSC cocultures at 72 h and 96 h allows for increased bone mineralization (unpublished data). Taken together, the dynamic interplay between polarized macrophages, especially pro-inflammatory M1 macrophages, and MSCs are key to optimal bone formation.
Further, the presence of M1 macrophages reduced ALP activity at 2 weeks of co-culture. The low ALP activity seen in the M1-MSC co-culture without celecoxib (Fig. 1A ) may be because ALP activity peaked earlier in co-culture and thus had subsided by week 2. We chose the 2 week time point as (1) our group has previously shown that ALP activity is the main osteoprogenitor marker early in differentiation (Day 5-14) in monocultures of MSCs and (2) that ALP activity is elevated in polarized macrophage-MC3T3 (pre-osteoblast cell line) co-cultures at 2 weeks. 13, 38 However, since we propose that M1 macrophages exert their pro-osteogenic effect on MSCs early in osteogenesis, we may have missed the apex of ALP activity by measuring at 2 weeks rather than an earlier time point. The pro-inflammatory environment mediated by the M1 macrophages may have more strongly stimulated MSCs to produce PGE2 and initiate the osteoblastic program earlier in culture than in the M0-MSC and M2-MSC cocultures. Moreover, we seeded our co-cultures at a 5:1 macrophage:MSC ratio (50k macrophages:10k MSCs), which likely further enhanced the pro-inflammatory setting mediated by the M1 macrophages. It has also been shown that LPS-stimulated macrophages can express ALP, so this additional source of ALP could have disrupted the expected ALP activity profile via macrophage-MSC cross-talk. 39 As we measured ALP at a single time point, we cannot say for certain how ALP activity evolved throughout co-culture. Despite the low ALP activity measured at 2 weeks, the M1-MSC group exhibited the most bone mineralization at 4 weeks (Fig. 1B) . Interestingly, the PGE2 secretion data at 2 weeks of culture more closely correlated with the bone mineralization trends at 4 weeks than with ALP activity at 2 weeks; PGE2 secretion was highest in the M1-MSC co-culture groups while ALP activity was the lowest in M1-MSC groups at 2 weeks (Figs. 1 and 2A) . These data highlight the importance of early PGE2 secretion in our co-culture system for ultimate bone mineralization, the most clinically important endpoint in the setting of fracture healing. . Osteoprotegerin (OPG) is negatively regulated by macrophages, especially polarized macrophages, in macrophage-MSC co-culture. After 3 weeks of co-culture, osteoprotegerin (OPG), the RANKL decoy receptor, was reduced in all macrophage-MSC co-culture groups compared to MSCs grown alone. This result suggests that macrophages decrease OPG secretion and may indirectly modulate osteoclast activity via the OPG-RANKL axis.
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Our study is consistent with previous work showing that the inhibition of COX-2 and PGE2 leads to impaired bone healing. 19, [40] [41] [42] [43] However, the effect of COX-2 inhibition on bone formation may be more nuanced and context-specific than previously stated. Yoon et al. proposed that bone formation processes may differ in inflammatory and non-inflammatory states: They found that human MSCs pre-treated with IL-1b as an inflammatory stimulus had impaired bone formation and osteoblastic differentiation when treated with continuous celecoxib for 2 weeks. 19 On the other hand, MSCs that were not treated with IL1b did not have reduced bone mineralization. 19 Similarly, in our study, we observed that the pro-inflammatory M1-MSC co-culture group had the most bone formation after 4 weeks of culture, and with disruption of the COX-2-PGE2 pathway by celecoxib, the M1-MSC co-culture had the most dramatic reduction in bone mineralization (Fig. 1B and 3B ). In the celecoxibtreated cultures, the MSC-only control had enhanced matrix mineralization with celecoxib treatment while osteogenesis was reduced in all macrophage-MSC cocultures (Fig. 3B) . Consistent with preliminary data from our group (data not shown), celecoxib seems to enhance osteogenesis of MSCs that are in an inflammation-free environment, suggesting that the role of COX-2 in bone formation is likely context-specific in an inflammatory response. These findings offer a mechanism for different pathways driving osteogenesis in inflammatory (e.g., injury) versus non-inflammatory (e.g., normal skeletogenesis, fetal bone development) states. Thus, COX-2 inhibition may only be detrimental in inflammatory states and further investigation is warranted for the role of COX-2 inhibition in other contexts.
Bone healing is regulated by pathways other than COX-2-PGE2 since near abolishment of PGE2 did not entirely inhibit bone formation in our co-culture system. These other pathways may be independent of the COX-2-PGE2 pathway or, more likely, intertwined with this signaling cascade. In a study comparing the effect of acetaminophen and celecoxib on bone fracture healing in rats, only celecoxib impaired fracture healing while acetaminophen, which may also in part inhibit the COX-2 pathway, had no negative effect on fracture healing by mechanical and radiographic observations. 44 Moreover, the Wnt/b-catenin pathway is an important regulator of embryonic skeletonogenesis and positively modulates osteoblasts in a timedependent manner during normal bone repair. 45 In response to mechanical loading, the Wnt/b-catenin signaling pathway is activated, and this activation works in concert with increased COX-2 and PGE2 secretion in osteocytes. 46, 47 These and other observations suggest more complex mechanisms underlying fracture healing.
We also found that the presence of macrophages reduced the secretion of OPG, the decoy RANKL receptor. OPG is known to be secreted by both macrophages and MSCs, so it is surprising that OPG protein in the supernatant was most dramatically reduced in the polarized macrophage (M1 and M2) co-cultures with greater than 60% reduction compared to MSCs grown alone and a statistically significant reduction compared to undifferentiated M0-MSCs. 48, 49 These findings suggest that the inflammatory environment mediated by macrophages negatively regulate OPG secretion in our co-culture system and thus may affect osteoclast activity along the OPG-RANKL axis. As both osteoclast and osteoblast activity are important for bone healing and remodeling, future studies should investigate how macrophages affect this osteoclast-osteoblast balance throughout the fracture healing process and in a variety of disease contexts.
This study has several limitations. First, in the present study, osteogenic markers were limited to ALP activity and Alizarin Red staining. Other groups have already shown that COX-2 regulates cbfa-1 and osterix in vivo. 18 Also, in the clinical setting, the most important outcome in a fracture would be formation of bone and healing of the fracture/defect, and thus, we highlight bone mineralization as measured by Alizarin Red staining. Second, we did not perform cell viability assays to determine the number of macrophages present at different time points in the co-culture. Previous work by our group has shown that macrophages plated with MSCs at a seeding density of 10 4 cells/well (24-well plate) survived co-culture for at least 10 days. 13 As such, we did not count cell numbers and did not normalize PGE2 protein levels with cell number. It is possible that the differential survival of the various macrophages phenotypes could have impacted our co-culture system. Others have shown that M0 and M2 macrophages survive longer than M1 macrophages, which have significantly fewer viable cells within the first week of culture. 50 Given this knowledge, the enhanced bone mineralization observed in the M1-MSC co-cultures is especially impressive as there are likely fewer M1 macrophages present as the co-culture progresses. This finding further supports our assertion that M1 macrophages exert their pro-osteogenic effect early in co-culture. Moreover, the celecoxib-treated and non-celecoxib-treated co-culture experiments were conducted separately and thus are not directly comparable. However, we controlled for any potential technical variations by conducting the experiments under same experimental conditions, by same personnel and using the same batch of cells, and highlight the different trends seen among experimental groups. Lastly, our current coculture system does not allow us to definitively confirm the proposed ideal M1 to M2 transition that may mediate enhanced bone formation. Other groups have shown that MSCs have an immunosuppressive role and modulate macrophages toward an M2 phenotype while our group has preliminary data (data not shown) that suggests that a M1 to M2 transition at 72 h or 96 h can enhance osteogenesis of macrophage-MSC co-cultures. [27] [28] [29] [30] Future studies are needed to characterize macrophage polarization and phenotype throughout co-culture. Despite these limitations, our study demonstrates that a strong, transient proinflammatory induction signal by M1 macrophages rather than continuous immune modulation plays a key role in mediating bone formation via the COX-2-PGE2 pathway.
CONCLUSION
In summary, polarized macrophages, especially proinflammatory M1 macrophages, enhance MSC osteogenesis and bone formation early in osteogenesis via the COX-2-PGE2 pathway. By promoting an initial inflammatory environment, M1 macrophages likely enable MSCs to elicit a robust response that promotes differentiation toward the osteoblast lineage, allowing for increased bone formation. These observations highlight the importance of an initial, transient inflammatory phase during fracture healing. Our results are consistent with current clinical practice of avoiding NSAID use early in acute bone injury and additionally provide mechanistic insight into why selective COX-2 inhibitors and NSAIDs generally may be detrimental to bone healing. Our findings also highlight the role of precise temporal immune modulation in optimizing bone repair for a variety of osteogenic disease processes and orthopaedic complications. As the role of COX-2 and PGE2 extends beyond musculoskeletal maladies into cancer biology, endocrinology, and cardiovascular health, it is imperative to gain a granular understanding of the nuances of COX-2 and PGE2 activity in all systems of the body. Moreover, all wound healing processes start with an inflammatory phase, so studying the complex role of macrophages in regulating inflammation and their interactions with MSCs provides an opportunity for developing treatments in other inflammatory processes, such as cardiac and neural tissue regeneration.
